|  | Univariate Analysis | Multivariate Analysis | ||
---|---|---|---|---|---|
Variable | n | RR(95% CI) | P | RR(95% CI) | P |
Age(year) | |||||
  ≤ 45 | 35 | 1 |  |  |  |
 >45 | 86 | 1.416(0.643–3.119) | 0.387 | n.a. | n.a. |
Histological grade | |||||
 I | 30 | 1 |  |  |  |
 II- III | 91 | 2.033(0.789–5.241) | 0.142 | n.a. | n.a. |
Positive lymph node | |||||
  ≤ 3 | 83 | 1 |  | 1 |  |
 >3 | 38 | 2.159(1.110–4.200) | 0.023 | 1.546(0.194–12.337) | 0.681 |
Lymphovascular invasion | |||||
 Absence | 73 | 1 |  | 1 |  |
 Presence | 48 | 3.588(1.784–7.216) | <0.001 | 2.507(1.154–5.447) | 0.020 |
Tumor size(cm) | |||||
  ≤ 2 | 30 | 1 |  |  |  |
 >2 | 91 | 2.338(0.907–6.031) | 0.079 | n.a. | n.a. |
ER | |||||
 Positive | 83 | 1 |  | 1 |  |
 Negative | 38 | 1.955(1.005–3.804) | 0.048 | 1.432(0.706–2.902) | 0.320 |
PR | |||||
 Positive | 57 | 1 |  |  |  |
 Negative | 64 | 1.159(0.593–2.264) | 0.666 | n.a. | n.a. |
Her2 | |||||
 Negative | 67 | 1 |  | 1 |  |
 Positive | 54 | 2.279(1.158–4.485) | 0.017 | 2.254(1.142–4.449) | 0.019 |
TNM stage | |||||
 I-II | 79 | 1 |  | 1 |  |
 III | 42 | 2.123(1.094–4.122) | 0.026 | 0.440(0.053–3.667) | 0.448 |
CTHRC1 expression | |||||
 Low | 56 | 1 |  | 1 |  |
 High | 65 | 4.072(1.778–9.329) | 0.001 | 2.559(1.017–6.439) | 0.046 |